TRCT
GMO

Tower Research Capital (TRC)’s General Moly, Inc. GMO Stock Holding History

Tower Research Capital (TRC)’s Portfolio GMO Stock Details GMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-61,422
Closed -$7K – 5650
2020
Q3 		$7K Buy
61,422
+47,900
+354% +$8.87K ﹤0.01% 4271
2020
Q2 		$3K Buy
+13,522
New +$2.67K ﹤0.01% 4458
2015
Q3 		– Sell
-29
Closed – – 5092
2015
Q2 		$0 Hold
29
– – ﹤0.01% 5288
2015
Q1 		$0 Sell
29
-7,712
-100% -$3.93K ﹤0.01% 5150
2014
Q4 		$4K Sell
7,741
-4,914
-39% -$2.77K ﹤0.01% 2963
2014
Q3 		$9K Buy
12,655
+1,539
+14% +$1.51K ﹤0.01% 2925
2014
Q2 		$13K Sell
11,116
-13,040
-54% -$13.6K ﹤0.01% 2171
2014
Q1 		$24K Buy
24,156
+24,016
+17,154% +$29.2K ﹤0.01% 1727
2013
Q4 		$0 Sell
140
-183
-57% -$263 ﹤0.01% 5082
2013
Q3 		$1K Buy
323
+292
+942% +$527 ﹤0.01% 4389
2013
Q2 		$0 Buy
+31
New +$61 ﹤0.01% 4005

Other funds holding GMO

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Tower Research Capital (TRC)'s GMO Position: Q4 2020 in Review

Tower Research Capital (TRC) sold out of General Moly, Inc. (GMO) in Q4 2020, closing a stake of 61,422 shares — an estimated $7K sold.

Tower Research Capital (TRC) first reported a position in GMO in Q2 2013 and held it in 11 quarters. The position peaked at $24K in Q1 2014. 7 funds tracked by Wall St. Rank hold GMO as of Q4 2020.

  • Tower Research Capital (TRC) reported no remaining General Moly, Inc. position as of Q4 2020 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 61,422 General Moly, Inc. shares in Q4 2020, an estimated $7K.
  • Tower Research Capital (TRC) first reported a position in General Moly, Inc. in Q2 2013 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s General Moly, Inc. position peaked at $24K in Q1 2014.
  • 7 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2020.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.